Human metabolites of brevetoxin PbTx-2: Identification and confirmation of structure
- PMID: 20600229
- PMCID: PMC2909374
- DOI: 10.1016/j.toxicon.2010.06.007
Human metabolites of brevetoxin PbTx-2: Identification and confirmation of structure
Abstract
Four metabolites were identified upon incubation of brevetoxin (PbTx-2) with human liver microsomes. Chemical transformation of PbTx-2 confirmed the structures of three known metabolites BTX-B5, PbTx-9 and 41, 43-dihydro-BTX-B5 and a previously unknown metabolite, 41, 43-dihydro-PbTx-2. These metabolites were also observed upon incubation of PbTx-2 with nine human recombinant cytochrome P450s (1A1, 1A2, 2C8, 2C9, 2C19, 2D6, 2E1, 3A4 and 3A5). Cytochrome P450 3A4 produced oxidized metabolites while other CYPs generated the reduced products.
Copyright 2010 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Figures


Similar articles
-
Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites.Mol Pharmacol. 2000 Dec;58(6):1341-8. doi: 10.1124/mol.58.6.1341. Mol Pharmacol. 2000. PMID: 11093772
-
Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes.Cancer Res. 1996 Jan 15;56(2):316-24. Cancer Res. 1996. PMID: 8542586
-
Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.Chem Res Toxicol. 2006 Jul;19(7):914-20. doi: 10.1021/tx0600090. Chem Res Toxicol. 2006. PMID: 16841959
-
Monoclonal antibodies and multifunctional cytochrome P450: drug metabolism as paradigm.J Clin Pharmacol. 2006 Mar;46(3):353-72. doi: 10.1177/0091270005285200. J Clin Pharmacol. 2006. PMID: 16490812 Review.
-
Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.Pharmacol Ther. 2013 Apr;138(1):103-41. doi: 10.1016/j.pharmthera.2012.12.007. Epub 2013 Jan 16. Pharmacol Ther. 2013. PMID: 23333322 Review.
Cited by
-
Chemodiversity of Brevetoxins and Other Potentially Toxic Metabolites Produced by Karenia spp. and Their Metabolic Products in Marine Organisms.Mar Drugs. 2021 Nov 24;19(12):656. doi: 10.3390/md19120656. Mar Drugs. 2021. PMID: 34940655 Free PMC article. Review.
-
Identification and cross-species comparison of in vitro phase I brevetoxin (BTX-2) metabolites in northern Gulf of Mexico fish and human liver microsomes by UHPLC-HRMS(/MS).Toxicon X. 2023 Jun 29;19:100168. doi: 10.1016/j.toxcx.2023.100168. eCollection 2023 Sep. Toxicon X. 2023. PMID: 37483846 Free PMC article.
-
Cellular and transcriptional responses of Crassostrea gigas hemocytes exposed in vitro to brevetoxin (PbTx-2).Mar Drugs. 2012 Mar;10(3):583-597. doi: 10.3390/md10030583. Epub 2012 Mar 5. Mar Drugs. 2012. PMID: 22611355 Free PMC article.
-
Contribution of Mass Spectrometry to the Advances in Risk Characterization of Marine Biotoxins: Towards the Characterization of Metabolites Implied in Human Intoxications.Toxins (Basel). 2023 Jan 22;15(2):103. doi: 10.3390/toxins15020103. Toxins (Basel). 2023. PMID: 36828418 Free PMC article. Review.
References
-
- Abraham A, Plakas SM, Flewelling LJ, El Said KR, Jester ELE, Granade HR, White KD, Dickey RW. Biomarkers of neurotoxic shellfish poisoning. Toxicon. 2008;52:237–245. - PubMed
-
- Cattet M, Geraci JR. Distribution and elimination of ingested brevetoxin (PbTx-3) in rats. Toxicon. 1993;31:1483–1486. - PubMed
-
- Ishida H, Nozawa A, Hamano H, Naoki H, Fujita T, Kaspar HF, Tsuji K. Brevetoxin B5, a new brevetoxin analog isolated from cockle Austrovenus stutchburyi in New Zealand, the marker for monitoring shellfish neurotoxicity. Tetrahedron Lett. 2004;45:29–33.
-
- Landsberg JH, Flewelling LJ, Naar J. Karenia brevis red tides, brevetoxins in the food web, and impacts on natural resources: decadal advancements. Harmful Algae. 2009;8(4):598–607.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources